Navigation Links
Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
Date:1/3/2008

DANBURY, Conn., Jan. 3 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today announced that the Company has completed enrollment of its two pivotal Phase III clinical trials of VIAject(TM), a rapid-acting injectable meal-time insulin for use by patients with Type 1 and Type 2 diabetes. The Company also announced its intention to build and operate a fill and finish manufacturing facility for VIAject(TM), on the campus of its current headquarters in Danbury, Connecticut.

"We are pleased to have completed enrollment of the VIAject(TM) clinical trials on schedule," commented Solomon S. Steiner, Ph.D., Chairman and Chief Executive Officer of Biodel. "We believe that VIAject(TM)'s superior pharmacokinetic and pharmacodynamic profile should improve the treatment of millions of patients with diabetes."

Biodel has now enrolled over 400 patients with Type 1 diabetes at approximately 60 clinical sites in the United States, Europe, and Asia, and over 400 patients with Type 2 diabetes at approximately 50 clinical sites in the United States, Europe, and Asia. Both studies are multi-center, open label and six months in duration, comparing the effects of VIAject(TM) to Humulin(R) R, the leading recombinant human insulin. Biodel expects to complete these trials and, if the trials are successful, the Company intends to submit a New Drug Application for VIAject(TM) to the Food and Drug Administration by the end of 2008.

To prepare for commercialization of VIAject(TM), the Company plans to build a fill and finish manufacturing facility which will be dedicated to manufacturing a full line of VIAject(TM) liquid formulations and presentations. The dedicated manufacturing facility will improve margins, provide superior quality control, and better inventory control. Biodel anticipates that the facility will cost under $15 million and will be available for commercial production in 2009.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceuti
'/>"/>

SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
3. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
4. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
5. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
6. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
7. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
8. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
9. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
10. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
11. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... China , announced that Sinovac Beijing, ... the Certificate of Good Manufacturing Practices for Pharmaceutical ... Food Administration (CFDA) for its proprietary vaccines, its ... filing and packaging facility. The GMP certificate covers ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 ... un destacado desarrollador y fabricante de herramientas de ... diagnosis y tratamiento de la enfermedad vascular periférica ... ensayo ADVISE ( Ad enosine V asodilator ... valuation) II durante la sesión de ensayo clínico ...
(Date:5/23/2013)... 23, 2013 Hearing health affects a man,s lifestyle, ... remain socially and professionally engaged, he should address any hearing ... that the Better Hearing Institute (BHI) is delivering ... Men,s Health Week , which leads up to and includes ... June 10 through June 16. To help ...
Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4
(Date:5/24/2013)... MD (PRWEB) May 24, 2013 The ... its growing base of clients. As a result of ... a presence in 20 states around the nation. ... medical transcription services to the healthcare industry . ... who use their years of clinical work experience ...
(Date:5/24/2013)... May 24, 2013 Based in ... a leading nationwide sales, installation and service provider ... and commercial applications. The company’s core products include ... lifts for mobility devices, pool lifts, turning automotive ... operates over 30 locations, primarily through its franchise ...
(Date:5/24/2013)... News) -- About one in five parents think they ... smoking, drinking or illicit drug use, a new U.S. ... at the Substance Abuse and Mental Health Services Administration ... one of the most influential forces helping to shape ... of teens repeatedly show that parents can make an ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The ... their favorite sunglasses all while learning how to ... replacement lenses. Contestants only need to upload ... sunglasses and "like" The Sunglass Fix on Facebook ... fix is the largest lens replacement online ...
(Date:5/24/2013)... A new investigational device - the Helio System (TF-FA) ... Transcatheter Heart Valve was successfully deployed in all four ... use in high-risk aortic insufficiency reported at EuroPCR 2013. ... to help stabilise the SAPIEN XT valve for patients ... are captured between the transcatheter heart valve and the ...
Breaking Medicine News(10 mins):Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Cortec Closes Equity Transaction with 101 Mobility 2Health News:Parents Underestimate Influence Over Teens' Substance Abuse: Survey 2Health News:Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win 2Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2
... -- Readmission rates have increased in many hospitals across ... elite academic medical centers, new research shows. About one ... within 30 days of being discharged for a medical ... for penalties -- reduced payments for readmissions -- for ...
... exposure to stressors in the Neonatal Intensive Care Unit ... and function of very preterm infants. According to the ... a journal published by Wiley-Blackwell on behalf of the ... experienced early exposure to stress displayed decreased brain size, ...
... , MONDAY, Oct. 3 (HealthDay News) -- The rate of ... rose dramatically over two decades, according to new government research. ... become the leading form of HPV-linked cancers, the researchers noted. ... percent of oral cancer samples tested positive for HPV. By ...
... Reporter , MONDAY, Oct. 3 (HealthDay News) -- Babies born very ... -- are five times more likely than full-term newborns to have ... study, based on Swedish medical databases, also found that being born ... seizure disorder as adults. Babies born as late as 35 to ...
... the strength of its synapses -- the connections between neurons ... a discovery that challenges conventional wisdom on the brain mechanisms ... brain "rhythm," or frequency, for changing synaptic strength. And further, ... to a different optimal frequency for learning. ...
... HealthDay Reporter , MONDAY, Oct. 3 (HealthDay News) ... recommended vaccination guidelines for their children, opting instead for ... delaying shots. And parents who do follow official ... schedule, according to new research. The findings alarm ...
Cached Medicine News:Health News:Hospital Readmission Rates on the Rise in Older Adults: Study 2Health News:Hospital Readmission Rates on the Rise in Older Adults: Study 3Health News:Preterm infants exposed to stressors in NICU display reduced brain size 2Health News:HPV-Linked Oral Cancers on the Rise, Study Finds 2Health News:HPV-Linked Oral Cancers on the Rise, Study Finds 3Health News:Preemies May Be at Higher Risk of Epilepsy Later in Life 2Health News:Preemies May Be at Higher Risk of Epilepsy Later in Life 3Health News:How the brain makes memories: Rhythmically! 2Health News:How the brain makes memories: Rhythmically! 3Health News:Some U.S. Parents Ignoring Vaccination Guidelines 2Health News:Some U.S. Parents Ignoring Vaccination Guidelines 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: